
EZYMF
Healthcare · Drug Manufacturers - Specialty & Generic · $182.2M market cap
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jul 19, 2022 | Before the open | 0.00 | -0.10 | — |
| Apr 28, 2022 | Before the open | — | -0.12 | — |
| Feb 17, 2022 | Before the open | — | -0.01 | — |
| Nov 2, 2021 | After the close | — | -0.00 | — |
| Jul 16, 2021 | Before the open | — | -0.00 | — |
| Apr 29, 2021 | Before the open | 0.00 | -0.02 | — |
| Feb 18, 2021 | Before the open | 0.13 | -0.01 | -105.5% |
| Nov 3, 2020 | Before the open | -0.04 | -0.01 | +75.0% |
| Jul 16, 2020 | Before the open | 0.00 | -0.08 | — |
| May 5, 2020 | Before the open | 0.00 | -0.01 | — |
| Feb 13, 2020 | Before the open | -0.06 | -0.04 | +33.3% |
| Nov 5, 2019 | Before the open | 0.00 | -0.00 | — |
| Jul 17, 2019 | Before the open | -0.08 | -0.11 | -37.5% |
Enzymatica AB, a life science company, develops and sells medical devices for infection-related diseases. The company's product includes ColdZyme mouth spray, which prevents common cold and reduces the duration of illness. It also provides enzyme formulations. The company sells mouth spray under the ViruProtect brand in Denmark; STADAProtect brand in Germany; Psysiomer Stop Virus brand in France; and Zerinol Virus…
| May 7, 2019 |
| Before the open |
| -0.08 |
| -0.09 |
| -12.5% |
| Feb 19, 2019 | Before the open | 0.00 | -0.01 | — |
| Oct 31, 2018 | Before the open | 0.00 | -0.01 | — |
| Jul 17, 2018 | Before the open | -0.10 | -0.16 | -60.0% |
| Apr 26, 2018 | Before the open | -0.11 | -0.11 | 0.0% |
| Feb 14, 2018 | Before the open | -0.16 | -0.06 | +62.5% |